MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
The New England Journal of Medicine Downloaded from nejm.org at UNL on June 7, 2016. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2010 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UNL on June 7, 2016. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2010 Massachusetts Medical Society. All rights reserved.
Suggest Documents
Preoperative carcinoembryonic antigen and prognosis of colorectal cancer. An independent prognostic factor still reliable.
Specific adhesion of carcinoembryonic antigen-bearing colorectal cancer cells to immobilized carcinoembryonic antigen.
Carcinoembryonic antigen and prognosis in patients with colon cancer.
Carcinoembryonic antigen (CEA) assays in obstructive colorectal cancer.
Carcinoembryonic antigen as a selective enhancer of colorectal cancer metastasis.
Carcinoembryonic antigen in hepatocellular cancer.
Association between carcinoembryonic antigen, carbohydrate antigen 19-9 and body mass index in colorectal cancer patients.
Assessment of the value of carcinoembryonic antigen reduction ratio as a prognosis factor in rectal cancer.
Tissue carcinoembryonic antigen in the prognosis of early invasive breast cancer.
The use of carcinoembryonic antigen in the clinical management of colorectal cancer.
Autoradiographic analysis of radiolabeled anti-carcinoembryonic antigen monoclonal antibody CEA102 in colorectal cancer using computed radiography.
Clinical value of carcinoembryonic antigen: diagnosis, prognosis, and follow-up of patients with cancer.
Expression of MCRS1 and MCRS2 and their correlation with serum carcinoembryonic antigen in colorectal cancer.
Assessing the prognostic value of preoperative carcinoembryonic antigen-specific T-cell responses in colorectal cancer.
Indium 111 ZCE-025 immunoscintigraphy in occult recurrent colorectal cancer with elevated carcinoembryonic antigen level.
Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab-based treatment response in metastatic colorectal cancer.
Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer.
Carcinoembryonic antigen expression level as a predictive factor for response to 5-fluorouracil in colorectal cancer.
The contribution of serum enzymes and carcinoembryonic antigen to the early diagnosis of metastatic colorectal cancer.
The Genome-Wide Analysis of Carcinoembryonic Antigen Signaling by Colorectal Cancer Cells Using RNA Sequencing.
Carcinoembryonic antigen and head and neck cancer.
Synergistic interaction between galectin-3 and carcinoembryonic antigen promotes colorectal cancer metastasis.
Carcinoembryonic antigen promotes colorectal cancer progression by targeting adherens junction complexes.
Carcinoembryonic antigen in osteosarcoma.
Carcinoembryonic antigen in prognosis of colorectal cancer.
The New England Journal of Medicine Downloaded from nejm.org at UNL on June 7, 2016. For personal use only. No other uses without permission. From the...
419KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Preoperative carcinoembryonic antigen and prognosis of colorectal cancer. An independent prognostic factor still reliable.
Specific adhesion of carcinoembryonic antigen-bearing colorectal cancer cells to immobilized carcinoembryonic antigen.
Carcinoembryonic antigen and prognosis in patients with colon cancer.
Carcinoembryonic antigen (CEA) assays in obstructive colorectal cancer.
Carcinoembryonic antigen as a selective enhancer of colorectal cancer metastasis.
Carcinoembryonic antigen in hepatocellular cancer.
Association between carcinoembryonic antigen, carbohydrate antigen 19-9 and body mass index in colorectal cancer patients.
Assessment of the value of carcinoembryonic antigen reduction ratio as a prognosis factor in rectal cancer.
Tissue carcinoembryonic antigen in the prognosis of early invasive breast cancer.
The use of carcinoembryonic antigen in the clinical management of colorectal cancer.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms